China Pharma (NYSE:CPHI) Earns Hold Rating from Analysts at StockNews.com

StockNews.com initiated coverage on shares of China Pharma (NYSE:CPHI) in a research note released on Friday. The firm issued a hold rating on the stock.

China Pharma Stock Performance

NYSE CPHI opened at $0.24 on Friday. The company has a current ratio of 0.79, a quick ratio of 0.26 and a debt-to-equity ratio of 0.22. The firm’s 50 day simple moving average is $0.22 and its 200 day simple moving average is $0.22. China Pharma has a 1 year low of $0.13 and a 1 year high of $0.44.

About China Pharma

China Pharma Holdings, Inc develops, manufactures, and markets generic and branded pharmaceutical, and biochemical products to hospitals and private retailers in the People’s Republic of China. The company provides products in the form of dry powder injectables, liquid injectables, tablets, capsules, and cephalosporin oral solutions.